27.8 C
New Delhi
Thursday 24 October 2019
Sci-Tech New treatment promises to curb cancer growth

New treatment promises to curb cancer growth

-

- Advertisment -

Delaware, United States — An experimental anti-cancer compound significantly reduced the average tumour weight of pancreatic cancers and ovarian cancers in preliminary studies, based on data released by Propanc Health Group Corporation. In the studies, mice inoculated with tumour cells were treated with injections of PRP, a combination of two proenzymes, trypsinogen and chymotrypsinogen.

In a pancreatic cancer study, tumours treated with PRP showed 86% inhibition compared with controls at 26 days after treatment. In a separate ovarian cancer study, researchers observed significant reductions in average tumor weight of 54% and 48% at the highest and lowest effective PRP doses, respectively. Furthermore, several mice in treatment groups of two different dosages appeared to have no tumours on final examination at the end of the study.

Based on the findings, Propanc, an emerging healthcare company, has filed a patent to specify the target effective dose range in preparation for human studies. Propanc’s research team focuses on developing new and proprietary treatments for colorectal, pancreatic and ovarian cancers.

“We are thrilled with the results and believe it now paves the way for scientific advice meetings with regulatory agencies to determine the development pathway for human studies,” Propanc CEO James Nathanielsz said in a statement. “As a result of achieving this significant milestone, we are convinced PRP, which is a combination of two proenzymes, trypsinogen and chymotrypsinogen, could become a breakthrough treatment in the fight against aggressive tumors like pancreatic and ovarian cancers,” he added.

The early results are “conclusive that PRP is effective in these tumor models,” Dr. Julian Kenyon, Propanc’s chief scientific officer, noted. “What is even more interesting is that it appears that tumor models with immune functioning mice show markedly increased inhibitory effects, which could possibly be attributed to the immunobiological effects of PRP, basically enhancing the immune response to assist with tumor regression,” he said. “As a result of this fine work undertaken with our preclinical research partners, we have identified an efficacious dose range which we can now use to target in human studies.”

Propanc is a publicly traded company based in Australia and has recently raised $4 million to support its research efforts. Visit this site for more information about the company and its work.

NewsUSA

Subscribe to our newsletter

You will get all our latest news and articles via email when you subscribe

The email despatches will be non-commercial in nature
Disputes, if any, subject to jurisdiction in New Delhi

Leave a Reply

Opinion

Aaditya Thackeray, Shiv Sena’s Existential Gambit

With leaders deserting Shiv Sena or debilitated with age, the party's footprint shrinking and Uddhav lacking Balasaheb's charisma, Aaditya had to step in to maintain the dynasty that has mostly been betrayed when politicians not from the Thackeray family were trusted

Karva Chauth: Faith, legend behind viewing the moon through a sieve

The legend and Karva Chauth rituals vary across Rajasthan, Uttar Pradesh, Himachal Pradesh, Madhya Pradesh, Haryana, Punjab, Delhi and, in south India, Andhra Pradesh

Pakistan-Occupied Kashmir, Here We Come!

Study Wuhan and Mamallapuram in the backdrop of the fact that things are not quite working out in China-Pakistan economic relations, notwithstanding the urge of the communist state to contain India and that of the Islamic state to challenge it

Slowdown Has Reasons Other Than GST, Demonetisation

When all economic sectors decline, the mood of the market turns sombre, turning investors all the more reluctant to pump in money; the interdependence of industries means that the slowdown suffered by one would affect many

Where China & India, Resisting & Improving Democracy, Meet

What you see in Hong Kong is China resisting democracy; what you see in Kashmir is India promoting it; a reasonably capitalist China does not offer freedom politically but India, held back at times by the choice of the people, is still opening up; there could be a point of convergence as the two nations move in opposite directions
- Advertisement -

Elsewhere

Unauthorised colonies in Delhi to be regularised: Modi Cabinet

The Modi government has finally come to terms with the ghastly sight of unauthorised colonies in Delhi that the Kejriwal dispensation had embraced long ago for votes

Ganguly on Dhoni: Champions don’t finish quickly

I have always said when I was left out and the entire world said 'I will never make it'. I came back and played for four years. Champions don't finish very quickly: Sourav Ganguly

Rabi crop growers to get higher MSP, Cabinet decides

The Cabinet has decided to grant a higher MSP for rabi crops recommended by the CACP; it will cost the exchequer an additional Rs 3,000 crore

Pension to arrive late by 2 years, but workers will not complain

Pushing the age of pension by two years, the government will save Rs 30,000 crore; the amount it owes to EPFO has been accumulating since 2014-15

Jharkhand sees pre-election opposition exodus to BJP

An exhaustive list of deserters among politicians of Jharkhand where switching parties is commonplace both pre-poll and post-election

You might also likeRELATED
Recommended to you

%d bloggers like this: